U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07700121) titled 'PICSTAT Pilot Study for CD8 PET/CT-Guided Lifileucel Treatment in Advanced Melanoma' on July 07.
Brief Summary: This prospective, single-center pilot study is being performed to find out whether Zr-89 crefmirlimab berdoxam "CD8 PET/CT" scans can improve the effectiveness of the tumor-infiltrating lymphocyte (TIL) therapy called lifileucel ("Study Treatment") in treating metastatic melanoma.
Participants must first provide consent to the companion protocol (UPCC 19426, PICSTAT CD8 PET) before being eligible to consent to this protocol.
Study Start Date: Oct. 01, 2026
Study Type: INTERVENTIONAL
Condition:
Unresectable or Metastat...